{"id":"W2119607431","doi":"10.1200/jco.2010.34.1578","title":"Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":338,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Temsirolimus; PTEN; Medicine; Internal medicine; Endometrial cancer; Chemotherapy; Progressive disease; Oncology; PI3K/AKT/mTOR pathway; Tensin; Cancer; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Cancer research; Biology; Signal transduction; Discovery and development of mTOR inhibitors","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03098215,0.0002283392,0.003213796,0.0001761398,0.0000372972,0.000004596837,0.0007549021,0.0003915659,0.0001333244],"category_scores_gemma":[0.0256511,0.0001195049,0.0006899582,0.0004166187,0.0004497487,0.00001128118,0.0002103296,0.0008899557,3.816839e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001015729,"about_ca_system_score_gemma":0.002952792,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000963312,"about_ca_topic_score_gemma":0.0004857392,"domain_scores_codex":[0.9838961,0.007171233,0.007644326,0.0003774946,0.0005752016,0.0003356009],"domain_scores_gemma":[0.9867634,0.003969888,0.008111633,0.0004807606,0.000428873,0.0002454832],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7786902,0.03826388,0.004945151,0.00002576919,0.001865652,0.00006362108,0.0005477245,0.00002216518,0.003106995,0.000006512009,0.0005227706,0.1719396],"study_design_scores_gemma":[0.4296708,0.5520993,0.005648987,0.0001211533,0.0008719961,0.00003004669,0.0006427934,0.00001220515,0.001607568,0.0001087446,0.009004135,0.0001821645],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934293,0.000565952,0.00006122137,0.0001213678,0.004491978,0.001210402,0.00002861915,0.000001926448,0.00008922456],"genre_scores_gemma":[0.9959275,0.001023345,0.0007328438,0.0001970478,0.001977363,0.00008030499,9.561498e-7,0.00002322955,0.0000374134],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5138355,"threshold_uncertainty_score":0.9978078,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3924537037993933,"score_gpt":0.5550164775171609,"score_spread":0.1625627737177676,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}